CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...

A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit ...

According to TipRanks.com, Wasserman is a 4-star analyst with an average return of 11.2% and a 43.0% success rate. Wasserman covers the Healthcare sector, focusing on stocks such as Intensity ...

The COVID pandemic likely began when the virus jumped from animals to humans, and didn’t start in a lab. But false narratives ...

The UK's life sciences plan has led to a split in opinions based within the pharma sector. A more detailed guide on what this ...

PRNewswire/ -- dbt Labs, the leader in standards for AI-ready structured data, today announced it has signed a strategic ...

Vinay Prasad has stepped down as head of the FDA’s biologics division just two months into the job, following growing ...

Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.

Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $6.87. The announcement from United Therapeutics is eagerly anticipated, with investors seeking news of surpassing ...

Nasdaq and S&P 500 hit record highs on Wall Street on Tuesday, 29 July 2025, as investors focused on the second-quarter ...

A week that began with the Cleburne Railroaders riding high on a 5-game winning streak into the all-star break, winning the American Association’s Home Run Derby and All-Star game MVP, quickly went ...